Cheshire, UK--(Marketwire - September 28, 2007) -
Protherics PLC
Total Voting Rights and Share Capital
London, UK; Brentwood, TN; 28 September 2007 - In conformity with the
Transparency Directive, Protherics PLC ("Protherics"), the international
biopharmaceutical company focused on critical care and cancer, notifies
the market of the following:
Protherics' issued share capital consists of 339,316,822 ordinary shares
with a nominal value of 2 pence each, with voting rights. Protherics does
not hold any ordinary shares in Treasury. Therefore, the total number of
voting rights in Protherics is 339,316,822.
The above figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, Protherics under the
Financial Services Authority's Disclosure and Transparency Rules.
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, David Yates +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange